Potentially functional polymorphisms in the ERCC2 gene and risk of Esophageal Squamous Cell Carcinoma in Chinese populations

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Zhu, Mei Ling ^a,b,c   He, Jing ^a,b   Wang, Mengyun ^a,b   Sun, Meng Hong ^a   Jin, Li ^b,d   Wang, Xiaofeng ^b,d   Yang, Ya Jun ^b,d   Wang, Jiu Cun ^b,d   Zheng, Leizhen ^c   Xiang, Jia Qing ^a,b   Wei, Qing Yi ^a,e  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d Fudan Taizhou Institute of Health Sciences   (China)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERCC2 PROTEIN, HUMAN; MESSENGER RNA; PHENYLALANINE 4 MONOOXYGENASE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ASIAN CONTINENTAL ANCESTRY GROUP; BIOSYNTHESIS; CARCINOMA, SQUAMOUS CELL; CHINA; DNA REPAIR; DRINKING BEHAVIOR; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRANSFORMED CELL LINE;

ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CHINA; DNA REPAIR; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PHENYLALANINE HYDROXYLASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; RNA, MESSENGER; SMOKING; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84923371728     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06281     Document Type: Article

References (44)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61, 69-90 (2011).
2. Hoeijmakers, J. H. Genome maintenance mechanisms for preventing cancer. Nature 411, 366-374 (2001).
3. Egly, J. M. The 14th Datta Lecture. TFIIH: from transcription to clinic. FEBS Lett 498, 124-128 (2001).
4. Lehmann, A. R. The xeroderma pigmentosum groupD(XPD) gene: one gene, two functions, three diseases. Genes Dev 15, 15-23 (2001).
5. Xing, D. et al. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer 100, 600-605, doi:10.1002/ijc.10528 (2002).
6. Chen, M. R. et al. Polymorphism of DNA repair gene XPD and XRCCl and its relationship with esophageal squamous cell carcinoma. Fudan Univ JMed Sci 35, 273-277, 281 (2008).
7. Huang, C. G. et al. Analysis of XPD genetic polymorphisms of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Mol Biol Rep 39, 709-714, doi:10.1007/s11033-011-0789-z (2012).
8. Li, R. Z. & Sun, J. Association between XPD gene polymorphisms and esophageal squamous cell carcinoma. Mol Med Rep 7, 674-678, doi:10.3892/mmr.2012.1215 (2013).
9. Wu, C. et al. Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions. Nat Genet 44, 1090-1097 (2012).
10. Wu, C. et al. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet 43, 679-684 (2011).
11. Wang, L. D. et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 42, 759-763 (2010).
12. Abnet, C. C. et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 42, 764-767 (2010).
13. Zhu, M. L. et al. Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations. PLoS One 7, e41500 (2012).
14. Ding, D. P.,Ma, W. L., He, X. F. & Zhang, Y. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies. Mol Biol Rep 39, 2533-2540 (2012).
15. Zhang,W. C. et al. Relationship between polymorphisms ofDNArepair genes and esophageal cancer susceptibility. Chin J Public Health 22, 557-558 (2006).
16. Wu, X. B. et al. Association of XPD gene polymorphisms with susceptibility of esophageal squamous cell carcinoma in Henan province. Chin J Public Health 28, 446-449 (2012).
17. Zhou, R. M. et al. Correlation between single nucleotide polymophism of DNA repair gene XPD and the risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Tumor 27, 118-122,133 (2007).
18. Casson, A. G. et al. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 26, 1536-1541 (2005).
19. Sung, P. et al. Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature 365, 852-855, doi:10.1038/365852a0 (1993).
20. Coin, F. et al. Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet 20, 184-188, doi:10.1038/2491 (1998).
21. Friedberg, E. C. How nucleotide excision repair protects against cancer. Nat Rev Cancer 1, 22-33, doi:10.1038/35094000 (2001).
22. Liu, R., Yin, L. H. & Pu, Y. P. Reduced expression of human DNA repair genes in esophageal squamous-cell carcinoma in china. J Toxicol Environ Health A 70, 956-963 (2007).
23. Vogel, U., Dybdahl, M., Frentz, G. & Nexo, B. A. DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes. Mutat Res 461, 197-210 (2000).
24. Minelli, C., Thompson, J. R., Abrams, K. R., Thakkinstian,A.&Attia, J. The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol 34, 1319-1328 (2005).
25. Shao, J., Gu, M., Xu, Z., Hu, Q. & Qian, L. Polymorphisms of the DNA gene XPD and risk of bladder cancer in a Southeastern Chinese population. Cancer Genet Cytogenet 177, 30-36 (2007).
26. Yin, J. et al. The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population. Cancer Lett 223, 219-226 (2005).
27. Chao, H. K.,Hsiao, K. J. & Su, T. S. A silentmutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Hum Genet 108, 14-19 (2001).
28. Vogel, U.,Hedayati, M.,Dybdahl, M.,Grossman, L.&Nexo, B. A. Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis 22, 899-904 (2001).
29. Feng, Z., Ni, Y., Dong, W., Shen, H. & Du, J. Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis. Mol Biol Rep 39, 57-69, doi:10.1007/s11033-011-0710-9 (2012).
30. Xue, H. et al. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis. PLoS One 7, e43431 (2012).
31. Dong, Y., Zhuang, L. & Ma, W. Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma. Tumour Biol 34, 1155-1160 (2013).
32. Yuan, L. et al. XPD Lys751Gln polymorphism and esophageal cancer risk: ametaanalysis involving 2288 cases and 4096 controls. World J Gastroenterol 17, 2343-2348 (2011).
33. Benhamou, S. & Sarasin, A. ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 17, 463-469 (2002).
34. Lunn, R. M. et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21, 551-555 (2000).
35. Rouissi, K. et al. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer 11, 101 (2011).
36. Cui, R. et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 137, 1768-1775 (2009).
37. Bodmer, W. & Bonilla, C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40, 695-701 (2008).
38. Wang, X. et al. Rationales, design and recruitment of the Taizhou Longitudinal Study. BMC Public Health 9, 223 (2009).
39. Zhu, M. L. et al. Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis. PLoS One 7, e36293 (2012).
40. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials 7, 177-188 (1986).
41. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-748 (1959).
42. Egger, M., Smith, G.D., Schneider, M.&Minder, C. Bias in meta-analysis detected by a simple, graphical test. Brit Med J 315, 629-634 (1997).
43. Holm, K., Melum, E., Franke, A. & Karlsen, T. H. SNPexp-A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC bioinformatics 11, 600 (2010).
44. Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L. & Rothman, N. Assessing the probability that a positive report is false: An approach formolecular epidemiology studies. J Natl Cancer I 96, 434-442 (2004).